ITM Radiopharma valuation, funding and investors
ITM Radiopharma works in radiopharmaceutical development and manufacturing, based in Garching bei München, Germany. Founded in 2004, it has about 659 employees.
VALUATION · TODAY
$2.61B −26% after Growth
Range $747M – $3.97B · Grade CTODAY
+12 MO
$1.00B
$2.00B
$3.00B
$4.00B
2005
2007
2009
2011
2013
2015
2017
2019
2021
2023
2025
2027
Growth $205M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY661 employees
+5%6m growth
+17%1y growth
+54%2y growth
250
500
750
Data from Feb 2022
Predicted in 1 yr $1.93B −26% vs today
Predicted next raise $256M if a round comes
Winding-down probability 0%
- Last round
- Growth · $205M · Jan 2024
- Valuation at last round
- $2.09B · implied
- Headcount
- 661 · up
- Grade
- C
- Founded
- 2004
ITM Radiopharma valuation today
VCMC values ITM Radiopharma at $2.6B today, with a range of $747M to $4.0B and a grade of C. The valuation starts from its last funding round, a growth round in Jan 2024.
Valuation by date (276 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2011 | $2.92M | $1.06M – $8.03M | $2.94M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2011 | $2.92M | $1.06M – $8.03M | $2.95M (+1%) | before first round | – | unknown | D | 0% |
| 1 Oct 2011 | $2.92M | $1.06M – $8.03M | $2.96M (+1%) | before first round | – | unknown | D | 0% |
| 1 Nov 2011 | $2.92M | $1.06M – $8.03M | $2.97M (+2%) | before first round | – | unknown | D | 0% |
| 1 Dec 2011 | $2.92M | $1.06M – $8.03M | $2.98M (+2%) | before first round | – | unknown | D | 0% |
| 1 Jan 2012 | $2.92M | $1.06M – $8.03M | $2.99M (+2%) | before first round | – | unknown | D | 0% |
| 1 Feb 2012 | $2.92M | $1.06M – $8.03M | $3.01M (+3%) | before first round | – | unknown | D | 0% |
| 1 Mar 2012 | $2.92M | $1.06M – $8.03M | $3.02M (+3%) | before first round | – | unknown | D | 0% |
| 1 Apr 2012 | $2.92M | $1.06M – $8.03M | $3.03M (+4%) | before first round | – | unknown | D | 0% |
| 1 May 2012 | $2.92M | $1.06M – $8.03M | $3.04M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jun 2012 | $2.92M | $1.06M – $8.03M | $3.05M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jul 2012 | $2.92M | $1.06M – $8.03M | $3.06M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2012 | $2.94M | $1.07M – $8.07M | $3.08M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2012 | $2.95M | $1.07M – $8.10M | $3.09M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2012 | $2.96M | $1.08M – $8.13M | $3.10M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2012 | $2.97M | $1.08M – $8.16M | $3.11M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2012 | $2.98M | $1.09M – $8.19M | $3.13M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2013 | $2.99M | $1.09M – $8.22M | $3.14M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2013 | $3.01M | $1.09M – $8.26M | $3.15M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2013 | $3.02M | $1.10M – $8.29M | $3.16M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2013 | $3.03M | $1.10M – $8.32M | $3.17M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2013 | $3.04M | $1.11M – $8.35M | $3.19M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2013 | $3.05M | $1.11M – $8.39M | $3.20M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2013 | $3.06M | $1.12M – $8.42M | $3.21M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2013 | $3.08M | $1.12M – $8.45M | $3.22M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2013 | $3.09M | $1.12M – $8.49M | $3.24M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2013 | $3.10M | $1.13M – $8.52M | $3.25M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2013 | $3.11M | $1.13M – $8.55M | $3.26M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2013 | $3.13M | $1.14M – $8.58M | $3.28M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2014 | $3.14M | $1.14M – $8.62M | $3.29M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2014 | $3.15M | $1.15M – $8.65M | $3.30M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2014 | $3.16M | $1.15M – $8.68M | $3.31M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2014 | $3.17M | $1.16M – $8.72M | $3.33M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2014 | $3.19M | $1.16M – $8.75M | $3.34M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2014 | $3.20M | $1.16M – $8.79M | $3.35M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2014 | $3.21M | $1.17M – $8.82M | $3.37M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2014 | $3.22M | $1.17M – $8.86M | $3.38M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2014 | $3.24M | $1.18M – $8.89M | $3.39M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2014 | $3.25M | $1.18M – $8.93M | $3.41M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2014 | $3.26M | $1.19M – $8.96M | $3.42M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2014 | $3.28M | $1.19M – $9.00M | $3.43M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2015 | $3.29M | $1.20M – $9.03M | $3.45M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $3.30M | $1.20M – $9.07M | $3.46M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $3.31M | $1.21M – $9.10M | $3.47M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $3.33M | $1.21M – $9.14M | $3.49M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $3.34M | $1.22M – $9.17M | $3.50M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $3.35M | $1.22M – $9.21M | $3.51M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $3.37M | $1.23M – $9.24M | $3.53M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $3.38M | $1.23M – $9.28M | $3.62M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $3.39M | $1.23M – $9.32M | $3.72M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $3.41M | $1.24M – $9.35M | $3.81M (+12%) | before first round | – | unknown | D | 0% |
| 1 Nov 2015 | $3.42M | $1.24M – $9.39M | $3.92M (+15%) | before first round | – | unknown | D | 0% |
| 1 Dec 2015 | $3.43M | $1.25M – $9.43M | $4.02M (+17%) | before first round | – | unknown | D | 0% |
| 1 Jan 2016 | $3.45M | $1.25M – $9.47M | $4.13M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $3.46M | $1.26M – $9.50M | $4.24M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $3.47M | $1.26M – $9.54M | $4.35M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $3.49M | $1.27M – $9.58M | $4.47M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $3.50M | $1.27M – $9.61M | $4.59M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $3.51M | $1.28M – $9.65M | $4.71M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $3.53M | $1.28M – $9.69M | $4.83M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $3.62M | $1.32M – $9.95M | $4.96M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $3.72M | $1.35M – $10.2M | $5.10M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $3.82M | $1.39M – $10.5M | $5.23M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $3.92M | $1.43M – $10.8M | $5.38M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $4.02M | $1.46M – $11.1M | $5.52M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $4.13M | $1.50M – $11.3M | $5.66M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $4.24M | $1.54M – $11.7M | $5.82M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $4.35M | $1.58M – $11.9M | $5.96M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $4.46M | $1.63M – $12.3M | $6.12M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $4.58M | $1.67M – $12.6M | $6.28M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $4.71M | $1.71M – $12.9M | $6.45M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $4.83M | $1.76M – $13.3M | $6.62M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $4.96M | $1.81M – $13.6M | $6.80M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $5.10M | $1.85M – $14.0M | $6.99M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $5.23M | $1.90M – $14.4M | $7.17M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2017 | $5.37M | $1.96M – $14.8M | $7.36M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2017 | $5.51M | $2.01M – $15.1M | $7.56M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2018 | $5.66M | $2.06M – $15.6M | $7.76M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2018 | $5.82M | $2.12M – $16.0M | $7.97M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2018 | $5.96M | $2.17M – $16.4M | $8.17M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2018 | $6.12M | $2.23M – $16.8M | $8.39M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2018 | $6.28M | $2.29M – $17.3M | $8.61M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2018 | $6.45M | $2.35M – $17.7M | $8.85M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2018 | $6.62M | $2.41M – $18.2M | $9.08M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2018 | $6.80M | $2.48M – $18.7M | $9.17M (+35%) | before first round | – | unknown | D | 0% |
| 1 Sep 2018 | $6.99M | $2.54M – $19.2M | $9.25M (+32%) | before first round | – | unknown | D | 0% |
| 1 Oct 2018 | $7.17M | $2.61M – $19.7M | $9.34M (+30%) | before first round | – | unknown | D | 0% |
| 1 Nov 2018 | $7.36M | $2.68M – $20.2M | $9.42M (+28%) | before first round | – | unknown | D | 0% |
| 1 Dec 2018 | $7.56M | $2.75M – $20.8M | $9.51M (+26%) | before first round | – | unknown | D | 0% |
| 1 Jan 2019 | $7.76M | $2.83M – $21.3M | $9.59M (+24%) | before first round | – | unknown | D | 0% |
| 1 Feb 2019 | $7.97M | $2.90M – $21.9M | $9.68M (+21%) | before first round | – | unknown | D | 0% |
| 1 Mar 2019 | $8.17M | $2.97M – $22.4M | $9.76M (+19%) | before first round | – | unknown | D | 0% |
| 1 Apr 2019 | $8.39M | $3.05M – $23.1M | $9.85M (+17%) | before first round | – | unknown | D | 0% |
| 1 May 2019 | $8.61M | $3.14M – $23.7M | $9.94M (+15%) | before first round | – | unknown | D | 0% |
| 1 Jun 2019 | $8.85M | $3.22M – $24.3M | $10.0M (+13%) | before first round | – | unknown | D | 0% |
| 1 Jul 2019 | $9.08M | $3.30M – $24.9M | $10.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2019 | $9.17M | $3.34M – $25.2M | $10.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2019 | $9.25M | $3.37M – $25.4M | $10.3M (+11%) | before first round | – | unknown | D | 0% |
| 1 Oct 2019 | $9.34M | $3.40M – $25.6M | $10.4M (+11%) | before first round | – | unknown | D | 0% |
| 1 Nov 2019 | $9.42M | $3.43M – $25.9M | $10.5M (+11%) | before first round | – | unknown | D | 0% |
| 1 Dec 2019 | $9.51M | $3.46M – $26.1M | $10.6M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jan 2020 | $9.59M | $3.49M – $26.4M | $10.7M (+11%) | before first round | – | unknown | D | 0% |
| 1 Feb 2020 | $9.68M | $3.52M – $26.6M | $10.8M (+11%) | before first round | – | unknown | D | 0% |
| 1 Mar 2020 | $9.76M | $3.55M – $26.8M | $10.9M (+11%) | before first round | – | unknown | D | 0% |
| 1 Apr 2020 | $9.85M | $3.59M – $27.1M | $11.0M (+11%) | before first round | – | unknown | D | 0% |
| 1 May 2020 | $9.94M | $3.62M – $27.3M | $11.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jun 2020 | $10.0M | $3.65M – $27.6M | $11.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jul 2020 | $10.1M | $3.69M – $27.8M | $11.3M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2020 | $10.2M | $3.72M – $28.1M | $11.4M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2020 | $10.3M | $3.75M – $28.3M | $11.5M (+11%) | before first round | – | unknown | D | 0% |
| 1 Oct 2020 | $10.4M | $3.79M – $28.6M | $11.6M (+11%) | before first round | – | unknown | D | 0% |
| 1 Nov 2020 | $10.5M | $3.82M – $28.8M | $11.7M (+11%) | before first round | – | unknown | D | 0% |
| 1 Dec 2020 | $10.6M | $3.86M – $29.1M | $11.8M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jan 2021 | $10.7M | $3.89M – $29.3M | $11.9M (+11%) | before first round | – | unknown | D | 0% |
| 1 Feb 2021 | $10.8M | $3.93M – $29.6M | $12.0M (+11%) | before first round | – | unknown | D | 0% |
| 1 Mar 2021 | $10.9M | $3.96M – $29.9M | $12.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Apr 2021 | $11.0M | $3.99M – $30.1M | $12.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 May 2021 | $11.1M | $4.03M – $30.4M | $12.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jun 2021 | $11.2M | $4.07M – $30.7M | $12.3M (+10%) | before first round | – | unknown | D | 0% |
| 1 Jul 2021 | $11.3M | $4.10M – $31.0M | $12.4M (+10%) | before first round | – | unknown | D | 0% |
| 1 Aug 2021 | $11.4M | $4.14M – $31.2M | $12.5M (+10%) | before first round | – | unknown | D | 0% |
| 1 Sep 2021 | $11.5M | $4.18M – $31.5M | $12.6M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2021 | $11.6M | $4.22M – $31.8M | $12.7M (+10%) | before first round | – | unknown | D | 0% |
| 1 Nov 2021 | $11.7M | $4.25M – $32.1M | $12.8M (+10%) | before first round | – | unknown | D | 0% |
| 1 Dec 2021 | $11.8M | $4.29M – $32.4M | $12.9M (+9%) | before first round | – | unknown | D | 0% |
| 1 Jan 2022 | $11.9M | $4.33M – $32.7M | $13.0M (+9%) | before first round | – | unknown | D | 0% |
| 1 Feb 2022 | $19.5M | $4.07M – $93.1M | $20.0M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Mar 2022 | $19.5M | $4.07M – $93.3M | $20.0M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Apr 2022 | $19.5M | $4.08M – $93.5M | $20.1M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 May 2022 | $19.6M | $4.09M – $93.7M | $20.1M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Jun 2022 | $19.6M | $4.10M – $93.9M | $20.1M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Jul 2022 | $19.7M | $4.11M – $94.1M | $20.2M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Aug 2022 | $19.7M | $4.12M – $94.3M | $20.2M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Sep 2022 | $19.8M | $4.13M – $94.5M | $20.3M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Oct 2022 | $19.8M | $4.14M – $94.7M | $20.3M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Nov 2022 | $19.8M | $4.15M – $95.0M | $20.4M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Dec 2022 | $19.9M | $4.15M – $95.2M | $20.4M (+3%) | before first round | 140 | unknown | D | 0% |
| 1 Jan 2023 | $40.1M | $9.85M – $139M | $41.1M (+3%) | before first round | 230 | growing | D | 0% |
| 1 Feb 2023 | $40.2M | $9.87M – $139M | $41.2M (+3%) | before first round | 230 | growing | D | 0% |
| 1 Mar 2023 | $40.2M | $9.89M – $139M | $41.3M (+3%) | before first round | 230 | growing | D | 0% |
| 1 Apr 2023 | $40.3M | $9.91M – $140M | $41.4M (+3%) | before first round | 230 | growing | D | 0% |
| 1 May 2023 | $40.4M | $9.93M – $140M | $41.5M (+3%) | before first round | 230 | growing | D | 0% |
| 1 Jun 2023 | $40.5M | $9.95M – $140M | $41.6M (+3%) | before first round | 230 | growing | D | 0% |
| 1 Jul 2023 | $40.6M | $9.98M – $140M | $41.7M (+3%) | before first round | 230 | growing | D | 0% |
| 1 Aug 2023 | $40.7M | $10.0M – $141M | $41.7M (+2%) | before first round | 230 | growing | D | 0% |
| 1 Sep 2023 | $29.5M | $6.16M – $141M | $30.1M (+2%) | before first round | 230 | unknown | D | 0% |
| 1 Oct 2023 | $53.7M | $13.2M – $186M | $54.7M (+2%) | before first round | 330 | growing | D | 0% |
| 1 Nov 2023 | $53.8M | $13.2M – $186M | $54.7M (+2%) | before first round | 330 | growing | D | 0% |
| 1 Dec 2023 | $53.9M | $13.2M – $186M | $54.7M (+2%) | before first round | 330 | growing | D | 0% |
| 1 Jan 2024 | $2.1B | $1.4B – $3.5B | $2.3B (+10%) | after a round | 330 | growing | B | 0% |
| 2 Jan 2024 | $2.1B | $1.4B – $3.5B | $2.3B (+10%) | after a round | 330 | growing | B | 0% |
| 1 Feb 2024 | $2.1B | $1.4B – $3.5B | $2.3B (+9%) | after a round | 330 | growing | B | 0% |
| 1 Mar 2024 | $2.1B | $1.4B – $3.5B | $2.3B (+8%) | after a round | 370 | growing | B | 0% |
| 1 Apr 2024 | $2.1B | $1.4B – $3.5B | $2.3B (+7%) | after a round | 370 | growing | B | 0% |
| 1 May 2024 | $2.2B | $1.4B – $3.5B | $2.3B (+7%) | after a round | 370 | growing | B | 0% |
| 1 Jun 2024 | $2.2B | $1.4B – $3.5B | $2.3B (+6%) | after a round | 370 | growing | B | 0% |
| 1 Jul 2024 | $2.2B | $1.4B – $3.6B | $2.4B (+6%) | after a round | 420 | growing | B | 0% |
| 1 Aug 2024 | $2.3B | $1.4B – $3.6B | $2.4B (+5%) | after a round | 430 | up | B | 0% |
| 1 Sep 2024 | $2.3B | $1.4B – $3.6B | $2.4B (+4%) | after a round | 430 | up | B | 0% |
| 1 Oct 2024 | $2.3B | $1.4B – $3.6B | $2.4B (+3%) | after a round | 430 | up | B | 0% |
| 1 Nov 2024 | $2.3B | $1.4B – $3.7B | $2.4B (+2%) | after a round | 450 | growing | B | 0% |
| 1 Dec 2024 | $2.4B | $1.4B – $3.7B | $2.4B (+1%) | after a round | 450 | growing | B | 0% |
| 1 Jan 2025 | $2.4B | $1.4B – $3.7B | $2.4B (0%) | after a round | 450 | growing | B | 0% |
| 1 Feb 2025 | $2.4B | $1.4B – $3.7B | $2.4B (0%) | after a round | 450 | growing | B | 0% |
| 1 Mar 2025 | $2.4B | $1.4B – $3.7B | $2.4B (0%) | after a round | 450 | growing | B | 0% |
| 1 Apr 2025 | $2.4B | $1.4B – $3.7B | $2.4B (0%) | after a round | 450 | growing | B | 0% |
| 1 May 2025 | $2.4B | $1.3B – $3.7B | $2.4B (0%) | after a round | 450 | up | B | 0% |
| 1 Jun 2025 | $2.4B | $1.3B – $3.7B | $2.4B (0%) | after a round | 450 | up | B | 0% |
| 1 Jul 2025 | $2.5B | $1.4B – $3.8B | $2.5B (0%) | after a round | 549 | growing | B | 0% |
| 1 Aug 2025 | $2.5B | $1.4B – $3.8B | $2.5B (0%) | after a round | 563 | growing | B | 0% |
| 1 Sep 2025 | $2.5B | $1.4B – $3.8B | $2.5B (0%) | after a round | 563 | growing | B | 0% |
| 1 Oct 2025 | $2.5B | $1.2B – $3.8B | $2.5B (0%) | after a round | 563 | up | B | 0% |
| 1 Nov 2025 | $2.4B | $1.1B – $3.7B | $2.4B (0%) | after a round | 470 | up | C | 0% |
| 1 Dec 2025 | $2.4B | $1.1B – $3.7B | $2.4B (0%) | after a round | 470 | up | C | 0% |
| 1 Jan 2026 | $2.4B | $963M – $3.7B | $2.4B (0%) | after a round | 470 | up | C | 0% |
| 1 Feb 2026 | $2.6B | $1.3B – $3.9B | $2.6B (0%) | after a round | 627 | growing | B | 0% |
| 1 Mar 2026 | $2.6B | $1.3B – $3.9B | $2.6B (0%) | after a round | 627 | growing | B | 0% |
| 1 Apr 2026 | $2.6B | $1.3B – $3.9B | $2.6B (0%) | after a round | 627 | growing | B | 0% |
| 1 May 2026 | $2.6B | $1.3B – $4.0B | $2.6B (0%) | after a round | 648 | growing | B | 0% |
| 1 Jun 2026 | $2.6B | $874M – $4.0B | $2.6B (-2%) | after a round | 648 | up | C | 0% |
| 1 Jul 2026 | $2.6B | $845M – $4.0B | $2.5B (-2%) | after a round | 648 | up | C | 0% |
| 1 Aug 2026 | $2.6B | $817M – $4.0B | $2.5B (-2%) | after a round | 648 | up | C | 0% |
| 1 Sep 2026 | $2.6B | $789M – $4.0B | $2.5B (-3%) | after a round | 648 | up | C | 0% |
| 1 Oct 2026 | $2.6B | $766M – $4.0B | $2.6B (-2%) | after a round | 661 | up | C | 0% |
| 24 Oct 2026 | $2.6B | $747M – $4.0B | $1.9B (-26%) | after a round | 661 | up | C | 0% |
Key facts about ITM Radiopharma
- Founded
- 2004
- Headquarters
- Garching bei München, Germany
- Employees
- about 659 +41% in a year
- Total raised
- $577M
- Funding rounds
- 3
- Last round
- Debt May 2025
ITM Radiopharma was founded in 2004 by Dr. Andrew Cavey, Dr. Christiane Kniphof, Dr. Thomas Lohr, Florian Huber, Konstantin Zhernosekov and Thomas J. Eysel.
ITM Radiopharma funding history
ITM Radiopharma has 3 funding rounds on record, from Apr 2021 to May 2025, $577M in total. None disclosed a valuation.
Debt 27 May 2025no round page
Led by Blue Owl Capital.
Sources: globenewswire.com, itm-radiopharma.com, cooley.com and 2 more
$263M
Growth Equity 1 Jan 2024
Led by Temasek; with BlackRock, Qatar Investment Authority, Athos Capital, Carbyne.
Sources: globenewswire.com, biopharmadive.com, itm-radiopharma.com and 2 more
$205M
$109M
ITM Radiopharma investors
7 investors have backed ITM Radiopharma; Blue Owl Capital, Petrichor and Temasek led at least one round.
- Blue Owl Capital lead
- Temasek lead
- BlackRock
- Carbyne
- Qatar Investment Authority
What ITM Radiopharma does
ITM Radiopharma works in pharmaceutical products, with 11 recorded offerings and customers in biotechnology, pharmaceuticals and healthcare.
ITM Isotope Technologies Munich SE, known as ITM Radiopharma, is a German biotechnology company engaged in the development and manufacturing of radiopharmaceuticals for targeted radionuclide therapy in oncology. The company operates as a vertically integrated entity, providing radioisotope manufacturing, radiopharmaceutical development, and the supply of radioisotopes for diagnostic and therapeutic applications. ITM Radiopharma serves clinical and pharmaceutical partners in the EU and the US, with operations in Germany and the United States.
Description from Veridion's company data.
Products and services
- Radiopharmaceutical Development and Manufacturing
- Radioisotope Manufacturing
- Targeted Radionuclide Therapy Development
- Radiopharmaceutical Research and Clinical Development
- Radioisotope Global Distribution
- Radiopharmaceutical Global Distribution
- Precision Oncology Solutions Development
- Radiodiagnostics Development and Manufacturing
- Therapeutic Radiopharmaceutical Manufacturing
- Diagnostic Radiopharmaceutical Manufacturing
- Strategic Pharmaceutical Partnership Development
Markets
- Biotechnology
- Pharmaceuticals
- Healthcare
Technology
- Targeted Radionuclide Therapy
- Precision Oncology
- Radioisotope Manufacturing for Radiopharmaceuticals
- Lutetium-177 (177Lu) for Targeted Radionuclide Therapy
- Actinium-225 (225Ac) for Targeted Radionuclide Therapy
Certifications
- FDA certified
- GDPR compliant
Business model
- Business-to-Business
- Manufacturing
Industry codes (NAICS)
- 325412 Pharmaceutical Preparation Manufacturing 70% match
- 541714 Research and Development in Biotechnology (except Nanobiotechnology) 30% match
Questions about ITM Radiopharma
What is ITM Radiopharma worth?
Valuation $2.6B (range $747M to $4.0B), as of 24 Oct 2026.
Has ITM Radiopharma raised money?
ITM Radiopharma has 3 funding rounds on record, from Apr 2021 to May 2025, $577M in total. None disclosed a valuation.
Who has invested in ITM Radiopharma?
Blue Owl Capital, Petrichor, Temasek, Athos Capital, BlackRock and Carbyne, and 1 more. Lead investors include Blue Owl Capital, Petrichor and Temasek.
How many people work at ITM Radiopharma?
About 659, up 41% over the last year. Headcount grew from 140 in Feb 2022 to 661 in Sep 2026.
What does ITM Radiopharma do?
ITM Radiopharma works in pharmaceutical products, with 11 recorded offerings and customers in biotechnology, pharmaceuticals and healthcare. Its main offerings are radiopharmaceutical development and manufacturing, radioisotope manufacturing and targeted radionuclide therapy development.
When was ITM Radiopharma founded, and where is it based?
ITM Radiopharma was founded in 2004 and is based in Garching bei München, Germany. It has about 659 employees, up 41% over the last year.